Biocept, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
NVTAInvitae Corp. -2.36%33.492.0%$161.43m
AMEDAmedisys, Inc. 1.43%207.7711.5%$124.62m
GHGuardant Health, Inc. -2.64%85.210.0%$85.96m
DVADaVita, Inc. 1.82%81.193.2%$83.95m
ONEM1Life Healthcare, Inc. 3.84%41.600.0%$68.36m
CHEChemed Corp. -0.32%473.4710.1%$61.84m
LHCGLHC Group, Inc. 0.39%181.322.9%$51.46m
NEONeoGenomics, Inc. -1.27%35.855.7%$41.26m
NTRANatera, Inc. -4.62%46.921.3%$38.37m
SDCSmileDirectClub, Inc. 2.23%8.260.0%$37.18m
BIOCBiocept, Inc. -1.98%0.703.0%$26.81m
MDMEDNAX, Inc. 4.06%17.6711.1%$24.43m
GTHGenetron Holdings Ltd. 5.68%13.780.0%$22.43m
ACHCAcadia Healthcare Co., Inc. 5.46%25.4227.1%$18.52m
BNRBurning Rock Biotech Ltd. -0.23%26.030.0%$15.50m

Company Profile

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.